<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr70-1759720X20912646">
 <label>70</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Koo</surname>
    <given-names>YX</given-names>
   </name>
   <name>
    <surname>Tay</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Teh</surname>
    <given-names>YE</given-names>
   </name>
  </person-group>, 
  <etal>et al</etal>
  <article-title>Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis</article-title>. 
  <source>Ann Hematol</source>
  <year>2011</year>; 
  <volume>90</volume>: 
  <fpage>1219</fpage>â€“
  <lpage>1223</lpage>.
  <pub-id pub-id-type="pmid">21520001</pub-id>
 </mixed-citation>
</ref>
